Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Christopher L. Cioffi. (2018) Glycine transporter-1 inhibitors: a patent review (2011–2016). Expert Opinion on Therapeutic Patents 28:3, pages 197-210.
Read now
Read now
Bartłomiej Pochwat, Agnieszka Pałucha-Poniewiera, Bernadeta Szewczyk, Andrzej Pilc & Gabriel Nowak. (2014) NMDA antagonists under investigation for the treatment of major depressive disorder. Expert Opinion on Investigational Drugs 23:9, pages 1181-1192.
Read now
Read now
Marco A Grados, Matt W Specht, Hyung-Mo Sung & Diandra Fortune. (2013) Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach. Expert Opinion on Drug Discovery 8:12, pages 1515-1527.
Read now
Read now
Joanna M Wierońska & Andrzej Pilc. (2013) Glutamate-based anxiolytic ligands in clinical trials. Expert Opinion on Investigational Drugs 22:8, pages 1007-1022.
Read now
Read now
Chun Yang, Wei Zhou, Xiaomin Li, Jianjun Yang, Bernadeta Szewczyk, Agnieszka Pałucha-Poniewiera, Ewa Poleszak, Andrzej Pilc & Gabriel Nowak. (2012) A bright future of researching AMPA receptor agonists for depression treatment. Expert Opinion on Investigational Drugs 21:5, pages 583-585.
Read now
Read now
Articles from other publishers (36)
Yuliya Knyahnytska, Reza Zomorrodi, Tyler Kaster, Daphne Voineskos, Alisson Trevizol & Daniel Blumberger. (2023) Neural Correlates of the DEEPP (Anti-suicidal Response to Ketamine in Treatment-Resistant Bipolar Depression) Study: Protocol for a Pilot, Open-Label Clinical Trial. JMIR Research Protocols 12, pages e41013.
Crossref
Crossref
Mehran Shayganfard. (2021) Are Essential Trace Elements Effective in Modulation of Mental Disorders? Update and Perspectives. Biological Trace Element Research 200:3, pages 1032-1059.
Crossref
Crossref
Bani Bandana Ganguly. 2022. Genetics and Neurobiology of Down Syndrome. Genetics and Neurobiology of Down Syndrome
275
320
.
Katarzyna Stachowicz, Paulina Misztak, Patrycja Pańczyszyn-Trzewik, Tomasz Lenda, Szymon Rzeźniczek & Magdalena Sowa-Kućma. (2021) Upregulation of the mGlu5 receptor and COX-2 protein in the mouse brain after imipramine and NS398, searching for mechanisms of regulation. Neurochemistry International 150, pages 105193.
Crossref
Crossref
Sheikh Salim, Sonone Pankaj, Verma Veena, Tripathi Chakra Dhar, Karim Bushra Ahmed & Meshram Girish Gulab. (2021) Comparative evaluation of anti-depressant effects of Citalopram, Ketamine and their combination in animal models of depression: A potential anti-depressant?. Open Journal of Pharmacology and Pharmacotherapeutics, pages 004-008.
Crossref
Crossref
Sheikh Salim, Sonone Pankaj, Verma Veena, Tripathi Chakar Dhar, Karim Bushra Ahmed & Meshram Girish Gulab. (2021) Ketamine; A better anti-depressant? An animal study evaluating the efficacy of citalopram, ketamine and their combination in animal models of depression. Journal of Neurology, Neurological Science and Disorders, pages 019-023.
Crossref
Crossref
Sheikh Salim, Sonone Pankaj, Tripathi Chakar Dhar, Verma Veena & Karim Bushra Ahmed. (2020) An experimental study targeting N-methyl-D-aspartate receptor in depression; beyond ketamine. Annals of Psychiatry and Treatment, pages 057-061.
Crossref
Crossref
Katarzyna Stachowicz. (2019) Behavioral consequences of co-administration of MTEP and the COX-2 inhibitor NS398 in mice. Part 1. Behavioural Brain Research 370, pages 111961.
Crossref
Crossref
Meysam Amidfar, Marie Woelfer, Gislaine Z. Réus, João Quevedo, Martin Walter & Yong-Ku Kim. (2019) The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research. Progress in Neuro-Psychopharmacology and Biological Psychiatry 94, pages 109668.
Crossref
Crossref
Ivana Perić, Andrijana Stanisavljević, Dragos Inta, Peter Gass, Undine E. Lang, Stefan Borgwardt & Dragana Filipović. (2019) Tianeptine antagonizes the reduction of PV+ and GAD67 cells number in dorsal hippocampus of socially isolated rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 89, pages 386-399.
Crossref
Crossref
Gislaine Zilli Réus, Airam Barbosa de Moura, Laura Araújo Borba, Helena Mendes Abelaira & João Quevedo. (2019) Strategies for Treatment-Resistant Depression: Lessons Learned from Animal Models. Complex Psychiatry 5:4, pages 178-189.
Crossref
Crossref
Jessica Wang, Phoebe Um, Barbra Dickerman & Jianghong Liu. (2018) Zinc, Magnesium, Selenium and Depression: A Review of the Evidence, Potential Mechanisms and Implications. Nutrients 10:5, pages 584.
Crossref
Crossref
Meysam Amidfar, Gislaine Z. Réus, Joao Quevedo & Yong-Ku Kim. (2018) The role of memantine in the treatment of major depressive disorder: Clinical efficacy and mechanisms of action. European Journal of Pharmacology 827, pages 103-111.
Crossref
Crossref
Katarzyna Stachowicz. (2018) The role of DSCAM in the regulation of synaptic plasticity: possible involvement in neuropsychiatric disorders. Acta Neurobiologiae Experimentalis 78:3, pages 210-219.
Crossref
Crossref
Weronika Stasiuk, Aleksandra Szopa, Anna Serefko, El?bieta Wyska, Katarzyna ?wi?der, Jaros?aw Dudka, Piotr Wla?Ewa Poleszak. (2016) Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice. Journal of Neural Transmission 124:3, pages 387-396.
Crossref
Crossref
Krzysztof Styczeń, Magdalena Sowa-Kućma, Marcin Siwek, Dominika Dudek, Witold Reczyński, Bernadeta Szewczyk, Paulina Misztak, Roman Topór-Mądry, Włodzimierz Opoka & Gabriel Nowak. (2016) The serum zinc concentration as a potential biological marker in patients with major depressive disorder. Metabolic Brain Disease 32:1, pages 97-103.
Crossref
Crossref
Urszula Doboszewska, Piotr Wlaź, Gabriel Nowak, Maria Radziwoń-Zaleska, Ranji Cui & Katarzyna Młyniec. (2017) Zinc in the Monoaminergic Theory of Depression: Its Relationship to Neural Plasticity. Neural Plasticity 2017, pages 1-18.
Crossref
Crossref
Meysam Amidfar, Gislaine Z. R?us, Jo?o Quevedo, Yong-Ku Kim & Mohammad Arbabi. (2017) Effect of co-administration of memantine and sertraline on the antidepressant-like activity and brain-derived neurotrophic factor (BDNF) levels in the rat brain. Brain Research Bulletin 128, pages 29-33.
Crossref
Crossref
Francis L. Pazini, Mauricio P. Cunha, Julia M. Rosa, André R. S. Colla, Vicente Lieberknecht, Ágatha Oliveira & Ana Lúcia S. Rodrigues. (2015) Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway. Molecular Neurobiology 53:10, pages 6818-6834.
Crossref
Crossref
Luís Félix, Luís Antunes, Sónia Campos, Carlos Venâncio & Ana Maria Coimbra. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
672
680
.
Urszula Doboszewska, Bernadeta Szewczyk, Magdalena Sowa-Kućma, Karolina Noworyta-Sokołowska, Paulina Misztak, Joanna Gołębiowska, Katarzyna Młyniec, Beata Ostachowicz, Mirosław Krośniak, Agnieszka Wojtanowska-Krośniak, Krystyna Gołembiowska, Marek Lankosz, Wojciech Piekoszewski & Gabriel Nowak. (2015) Alterations of Bio-elements, Oxidative, and Inflammatory Status in the Zinc Deficiency Model in Rats. Neurotoxicity Research 29:1, pages 143-154.
Crossref
Crossref
Karolina Podkowa, Szymon Rzeźniczek, Marcin Marciniak, Francine Acher, Andrzej Pilc & Agnieszka Pałucha-Poniewiera. (2015) A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action. Neuropharmacology 97, pages 338-345.
Crossref
Crossref
Małgorzata Wolak, Agata Siwek, Bernadeta Szewczyk, Ewa Poleszak, Beata Bystrowska, Andrzej Moniczewski, Anita Rutkowska, Katarzyna Młyniec & Gabriel Nowak. (2015) Evaluation of the role of NMDA receptor function in antidepressant-like activity. A new study with citalopram and fluoxetine in the forced swim test in mice. Pharmacological Reports 67:3, pages 490-493.
Crossref
Crossref
Bartlomiej Pochwat, Magdalena Sowa-Kucma, Katarzyna Kotarska, Paulina Misztak, Gabriel Nowak & Bernadeta Szewczyk. (2014) Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA/BDNF pathway. Psychopharmacology 232:2, pages 355-367.
Crossref
Crossref
Helena Domin, Bernadeta Szewczyk, Monika Woźniak, Anika Wawrzak-Wleciał & Maria Śmiałowska. (2014) Antidepressant-like effect of the mGluR5 antagonist MTEP in an astroglial degeneration model of depression. Behavioural Brain Research 273, pages 23-33.
Crossref
Crossref
Bartłomiej Pochwat, Bernadeta Szewczyk, Magdalena Sowa-Kucma, Agata Siwek, Urszula Doboszewska, Wojciech Piekoszewski, Piotr Gruca, Mariusz Papp & Gabriel Nowak. (2013) Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits. The International Journal of Neuropsychopharmacology 17:03, pages 393-405.
Crossref
Crossref
Agnieszka Pałucha-Poniewiera, Piotr Brański, Joanna M. Wierońska, Katarzyna Stachowicz, Anna Sławińska & Andrzej Pilc. (2013) The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent. Psychopharmacology 231:1, pages 97-107.
Crossref
Crossref
Magdalena Sowa-Kućma, Bernadeta Szewczyk, Krystyna Sadlik, Wojciech Piekoszewski, Franciszek Trela, Włodzimierz Opoka, Ewa Poleszak, Andrzej Pilc & Gabriel Nowak. (2013) Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims. Journal of Affective Disorders 151:3, pages 924-931.
Crossref
Crossref
Hongli Sun, Lixia Guan, Zhongliang Zhu & Hui Li. (2013) Reduced Levels of NR1 and NR2A with Depression-Like Behavior in Different Brain Regions in Prenatally Stressed Juvenile Offspring. PLoS ONE 8:11, pages e81775.
Crossref
Crossref
Julia D. I. Meuwese, Anouk M. van Loon, H. Steven Scholte, Philipp B. Lirk, Nienke C. C. Vulink, Markus W. Hollmann & Victor A. F. Lamme. (2013) NMDA Receptor Antagonist Ketamine Impairs Feature Integration in Visual Perception. PLoS ONE 8:11, pages e79326.
Crossref
Crossref
Marcin Siwek, Bernadeta Szewczyk, Dominika Dudek, Krzysztof Styczeń, Magdalena Sowa-Kućma, Katarzyna Młyniec, Agata Siwek, Leszek Witkowski, Bartłomiej Pochwat & Gabriel Nowak. (2013) Zinc as a marker of affective disorders. Pharmacological Reports 65:6, pages 1512-1518.
Crossref
Crossref
Agnieszka Pa?ucha-Poniewiera, Joanna M. Wiero?ska, Piotr Bra?ski, Grzegorz Burnat, Barbara Chru?cicka & Andrzej Pilc. (2013) Is the mGlu5 receptor a possible target for new antidepressant drugs?. Pharmacological Reports 65:6, pages 1506-1511.
Crossref
Crossref
Małgorzata Wolak, Agata Siwek, Bernadeta Szewczyk, Ewa Poleszak, Andrzej Pilc, Piotr Popik & Gabriel Nowak. (2013) Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test. Pharmacological Reports 65:4, pages 991-997.
Crossref
Crossref
Andrzej Pilc, Joanna M. Wierońska & Phil Skolnick. (2013) Glutamate-Based Antidepressants: Preclinical Psychopharmacology. Biological Psychiatry 73:12, pages 1125-1132.
Crossref
Crossref
Katarzyna M?yniec, Bogus?awa Budziszewska, Witold Reczy?ski, Urszula Doboszewska, Andrzej Pilc & Gabriel Nowak. (2013) Zinc deficiency alters responsiveness to antidepressant drugs in mice. Pharmacological Reports 65:3, pages 579-592.
Crossref
Crossref
Daniel C. Mathews, Ioline D. Henter & Carlos A. ZarateJrJr. (2012) Targeting the Glutamatergic System to Treat Major Depressive Disorder. Drugs 72:10, pages 1313-1333.
Crossref
Crossref